Skip to main content
. 2024 Oct 28;13(10):2847–2852. doi: 10.21037/tlcr-24-444

Figure 2.

Figure 2

Clinical course. Durva, durvalumab; Treme, tremelimumab; CBDCA, carboplatin; nab-PTX, nab-paclitaxel; AST, aspartate transaminase; ALT, alanine transaminase; G, grade; mPSL, methylprednisolone; COVID-19, coronavirus disease 2019; CRS, cytokine releasing syndrome; IVIG, intravenous immunoglobulin; TCZ, tocilizumab; HD, hemodialysis; CMV, cytomegalovirus; Fig, figure.